Tiziana Life Sciences (TLSA) Operating Leases (2019 - 2025)

Tiziana Life Sciences (TLSA) has reported Operating Leases for 7 consecutive years, with $234000.0 the latest figure, recorded in Q4 2025.

• Quarterly Operating Leases rose 120.75% year-over-year to $234000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $234000.0 (up 120.75% YoY) and the FY2025 annual result came in at $234000.0, up 120.75% from the prior year.
• Operating Leases rose to $234000.0 in Q4 2025 per TLSA's latest filing, from $106000.0 in the prior quarter.
• Over the last five years, Operating Leases for TLSA reached as high as $420000.0 in Q2 2021 and fell as low as $106000.0 in Q4 2024.
• A 5-year average of $199800.0 and a median of $130000.0 in 2022 frame the typical range for Operating Leases.
• Annual changes were most pronounced in 2023 — Operating Leases declined 16.15% — and 2025, when it jumped 120.75%.
• Year by year, Operating Leases stood at $420000.0 in 2021, then plunged by 69.05% to $130000.0 in 2022, then dropped by 16.15% to $109000.0 in 2023, then decreased by 2.75% to $106000.0 in 2024, then surged by 120.75% to $234000.0 in 2025.
• According to Business Quant data, Operating Leases over the past three periods registered $234000.0, $106000.0, and $109000.0 for Q4 2025, Q4 2024, and Q4 2023 respectively.